Wow, 72 hours ago no one even heard the name Omicron variant. Now, in less than three days, a variant has been identified, global travel has been halted, states of emergency have been declared, and now we see a pharmaceutical company announcing the variant specific vaccine trial that will begin in the U.S. in a few weeks. This government relationship with Big Pharma is certainly generating some fast action, eh?
If a person was cynically inclined; while knowing governments’ need to control inflation yet cannot raise interest rates or stop purchasing debt because current legislative spending continues – a remarkable control option would be to halt demand; and a person might think this was suspicious, or something.
Nov 26 (Reuters) – Novavax Inc said on Friday it had started working on a version of its COVID-19 vaccine to target the variant detected in South Africa and would have the shot ready for testing and manufacturing in the next few weeks.
The company’s COVID-19 shot contains an actual version of the virus’ spike protein that cannot cause disease but can trigger the immune system. The vaccine developer said it had started developing a spike protein specifically based on the known genetic sequence of the variant, B.1.1.529.
read more:
Replies